天津美吉生物医药科技有限公司成立，注册资本1000万人民币

Core Viewpoint - Tianjin Meiji Biopharmaceutical Technology Co., Ltd. has been established with a registered capital of 10 million RMB, fully owned by Shanghai Meiji Biopharmaceutical Technology Co., Ltd. [1] Company Overview - The legal representative of Tianjin Meiji Biopharmaceutical Technology Co., Ltd. is Huang Huasheng [1] - The company is classified under the scientific research and technical service industry, specifically in engineering and technical research and experimental development [1] - The registered address is Room 101, No. 6 Factory, New Creation Road, Core Area of Jingjin Industrial City, Wuqing Development Zone, Tianjin [1] - The company type is a limited liability company (sole proprietorship) with an operating period until February 13, 2026, with no fixed term thereafter [1] Shareholding Structure - Shanghai Meiji Biopharmaceutical Technology Co., Ltd. holds 100% of the shares in Tianjin Meiji Biopharmaceutical Technology Co., Ltd. [1] Business Scope - The business scope includes technical services, development, consulting, communication, transfer, and promotion; medical research and experimental development; manufacturing of specialized chemical products (excluding hazardous chemicals); import and export of goods and technology; sales of specialized chemical products (excluding hazardous chemicals); conference and exhibition services (subject to approval for overseas exhibitions); sales of mechanical and electronic products [1] - The company is also authorized to conduct second-class value-added telecommunications business, subject to approval by relevant authorities [1]